Results 31 to 40 of about 18,807 (182)

A Novel Reduction Strategy of Clarithromycin Resistance in Helicobacter pylori [PDF]

open access: yesJundishapur Journal of Microbiology, 2014
Antibiotic resistance is a major therapeutic problem in patients infected with Helicobacter pylori. H. pylori clarithromycin resistant mutants have been evolved during antibiotic therapy, this is mainly due to 23s rRNA point mutations.In the present study, we investigated anti-mutational features of four traditionally Iranian medicinal plants on three ...
Tadjrobehkar, Omid, Abdollahi, Hamid
openaire   +2 more sources

Clarithromycin overcomes resistance to lenalidomide and dexamethasone in multiple myeloma [PDF]

open access: yesAmerican Journal of Hematology, 2014
The combination of clarithromycin, lenalidomide and dexamethasone (BiRd) has led to highly durable responses in newly diagnosed myeloma. However, the ability of clarithromycin to overcome resistance to lenalidomide and dexamethasone (Rd) is not known.
Nilanjan, Ghosh   +5 more
openaire   +2 more sources

Lack of association between rrl and erm(41) mutations and clarithromycin resistance in Mycobacterium abscessus complex

open access: yesMemorias do Instituto Oswaldo Cruz
BACKGROUND Mycobacterium abscessus complex (MABC) includes species with high resistance rates among mycobacterial pathogens. In fact, MABC infections may not respond to clarithromycin treatment, which has historically been very effective against MABC ...
Maiara dos Santos Carneiro   +3 more
doaj   +1 more source

CYP3A5 genetic variability influences sildenafil and metabolite in pulmonary hypertension

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Interindividual variability in sildenafil response among pulmonary hypertension patients (PH) may be influenced by CYP3A5 polymorphisms. CYP3A5*3 allele reduces CYP3A5 activity and affects sildenafil metabolism. This study investigated the associations between CYP3A5 genotype and plasma concentrations of sildenafil and N‐desmethyl sildenafil, as ...
Pranisa Wongwien   +7 more
wiley   +1 more source

Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis [PDF]

open access: yesEuropean Respiratory Journal, 2017
Clarithromycin had a good tolerability and safety profile as assessed in MDR-TB patients receiving prolonged treatment http://ow.ly ...
Anne-Fleur Louise Van der Paardt   +14 more
openaire   +3 more sources

Management of Antibiotic-Resistant Helicobacter pylori Infection: Perspectives from Vietnam

open access: yesGut and Liver, 2019
Antibiotic resistance is the most important factor leading to the failure of eradication regimens. This review focuses on the prevalence of Helicobacter pylori primary and secondary resistance to clarithromycin, metronidazole, amoxicillin, levofloxacin ...
Vu Van Khien   +9 more
doaj   +1 more source

Targeting neutrophil extracellular traps in metabolic and immune niche: Nanomaterials for diabetes tissue regeneration

open access: yesBMEMat, EarlyView.
The effects of NETs on regeneration of various diabetic tissues, and strategies targeting NETs for diabetes tissue regeneration. In the diabetic environment, NETs undergo complex metabolic and immune reprogramming, leading to dynamic changes in antibacterial and proinflammatory functions, and affecting regeneration of multiple systemic tissues.
Xinyi Jiang   +6 more
wiley   +1 more source

Advanced nanotherapeutics for combating ocular infections: Rational design, antimicrobial mechanisms, and therapeutic breakthroughs

open access: yesBMEMat, EarlyView.
Nanomaterials revolutionize ocular infection treatment by enabling targeted drug delivery and enhanced antimicrobial efficacy against resistant pathogens. This review systematically explores their rational design, multimodal mechanisms, and translational potential for next‐generation anti‐infective therapies.
Yujia Liu   +7 more
wiley   +1 more source

Rapid screening of clarithromycin resistance in Helicobacter pylori by pyrosequencing [PDF]

open access: yesJournal of Medical Microbiology, 2007
Helicobacter pylori infections can be effectively treated with clarithromycin, a macrolide, in combination with other antibiotics, such as amoxicillin, tetracycline or metronidazole. The failure of H. pylori eradication is mainly associated with macrolide-resistant strains.
Karen-Anja, Moder   +3 more
openaire   +2 more sources

Helicobacter pylori Resistance to Clarithromycin in the Russian Federation [PDF]

open access: yesEffective Pharmacotherapy, 2020
Purpose – the systematization of data on the resistance of Helicobacter pylori to clarithromycin in the Russian Federation. Material and methods. Necessary investigations were searched in the electronic databases MEDLINE/PubMed, EMBASE, Cochrane, and the Russian Science Citation Index (RSCI), published between January and September, 2020.
I.V. Mayev   +8 more
openaire   +1 more source

Home - About - Disclaimer - Privacy